SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001999371-24-012479
Filing Date
2024-09-26
Accepted
2024-09-26 18:28:15
Documents
2
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP altium-sc13g_092624.htm SC 13G 78185
2 JOINT ACQUISITION STATEMENT ex-1.htm EX-1 6281
  Complete submission text file 0001999371-24-012479.txt   86200
Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Subject) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94408 | Film No.: 241330138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)